Market and Trading Information for FRESENIUS SE+CO.KGAA O.N. (Germany)
The following details are available for trading and market data about the stock of FRESENIUS SE+CO.KGAA O.N. as of writing. Currency is EUR.
Current Share Price:
EUR € 28.30
Previous Year's Closing Price:
EUR € 26.16
Percentage Price Change (YTD):
8.18%
Market Cap:
€ 15.94 billion
52-week Price Range:
23.38 - 31.15
Dividend Per Share:
0.92
EPS (TTM):
1.67
Price-Earnings (Trailing):
16.95
Price-Earnings (Forward):
6.64
Currency:
EUR €
Company Profile and Business Description for FRESENIUS SE+CO.KGAA O.N.
Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs, including intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products that are used in the collection and processing of blood components, as well as in transfusion medicine and cell therapy. As of December 31, 2019, this segment operated 86 hospitals, approximately 125 outpatient clinics, and 8 prevention centers. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. Fresenius SE & Co. KGaA has a strategic partnership with Humacyte Inc. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Stock Screener for Germany Stocks (Sector-wise)
Peer / Competitor Companies of Medical Care Facilities Sector of Germany
Along with Fresenius SE & Co. KGaA, the following other peer (competitor) companies also exist within the same Medical Care Facilities - Healthcare sector of Germany whose company profile and dividend history is as follows:
▶ FRESEN.MED.CARE KGAA O.N. (FME): Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in....See Detailed Company Profile
▶ M1 KLINIKEN AG O.N. (M12): M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Germany, Austria, the Netherlands,....See Detailed Company Profile
▶ MATERNUS-KLI.AG O.N. (MAK): Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate....See Detailed Company Profile
▶ MEDICLIN AG (MED): MEDICLIN Aktiengesellschaft operates hospitals in Germany. It operates through Post-Acute, Acute, and Other Activities segments. The company....See Detailed Company Profile
▶ RHOEN-KLINIKUM O.N. (RHK): RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany.....See Detailed Company Profile
▶ VITA 34 AG NA O.N. (V3V): VITA 34 AG engages in the collection, preparation, cryopreservation and storage of stem cells from umbilical cord blood and tissue in Europe. It....See Detailed Company Profile
Stock Lists of Other Germany Healthcare Subsectors: